Enhancer ID: | E_02_0006 |
Species: | mouse |
Position : | chr7:34815932-34817932 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Myelodysplastic disease |
Pubmed ID: | 29343483 |
Enhancer experiment: | RT-qPCR |
Enhancer experiment description: | Mechanistically, we demonstrate that NR4A1/3 restrict HSC proliferation in part through activation of a C/EBP?-driven anti-proliferative network by directly binding to a hematopoietic-specific Cebpa enhancer and activating Cebpa transcription. |
Target gene : | Cebpa(C/ebpalpha,CBF-A,Cebp) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Mechanistically, we demonstrate that NR4A1/3 restrict HSC proliferation in part through activation of a C/EBP?-driven anti-proliferative network by directly binding to a hematopoietic-specific Cebpa enhancer and activating Cebpa transcription. |
TF name : | -- |
TF experiment: | RT-qPCR |
TF experiment description: | Mechanistically, we demonstrate that NR4A1/3 restrict HSC proliferation in part through activation of a C/EBP?-driven anti-proliferative network by directly binding to a hematopoietic-specific Cebpa enhancer and activating Cebpa transcription. |
Enhancer function : | Mechanistically, we demonstrate that NR4A1/3 restrict HSC proliferation in part through activation of a C/EBP?-driven anti-proliferative network by directly binding to a hematopoietic-specific Cebpa enhancer and activating Cebpa transcription. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Mechanistically, we demonstrate that NR4A1/3 restrict HSC proliferation in part through activation of a C/EBP?-driven anti-proliferative network by directly binding to a hematopoietic-specific Cebpa enhancer and activating Cebpa transcription. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|